DexCom (DXCM) shares are in the spotlight after the company delivered better-than-expected second quarter revenues. However, a softer full-year outlook has drawn investor caution. Sector-wide trade ...

Dublin, Oct. 21, 2025 (GLOBE NEWSWIRE) -- The "DexCom Inc (DXCM) - Product Pipeline Analysis, 2025 Update" has been added to ResearchAndMarkets.com's offering. This analytical report serves as a ...

The Dexcom G7 Continuous Glucose Monitoring (CGM) System, shown here with an iPhone and an Apple Watch. This story was originally published on MedTech Dive. To receive daily news and insights, ...

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include ...

Explore DexCom stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for DXCM. Fiserv, eBay, And Garmin Are Among Top 10 Large Cap Losers Last Week (Oct. 27-Oct. 31): ...

InvestingPro analysis reveals that DexCom maintains a healthy current ratio of 1.52 and operates with moderate debt levels, suggesting strong operational stability. DexCom faces what Piper Sandler ...

People with Type 1 diabetes are estimated to make up to 180 more decisions a day than someone without the disease, according to a study from Stanford University. Each meal, workout, or night’s sleep ...

In other recent news, DexCom has been the focus of several analyst reports and market developments. Piper Sandler maintained an Overweight rating with a $100 price target, expressing confidence in ...

13 analysts have expressed a variety of opinions on DexCom (NASDAQ:DXCM) over the past quarter, offering a diverse set of opinions from bullish to bearish. The table below provides a snapshot of their ...